Selegiline (Deprenyl)
Selegiline (l-deprenyl, Eldepryl® or Anipryl® [veterinary]) is a drug used for the treatment of early-stage Parkinson's disease and senile dementia. In normal clinical doses it is a selective MAO-B inhibitor, however in very large doses (>25 mg in a typical adult) it loses its specificity and also inhibits MAO-A. Since it is selective for MAO-B, no special dietary restrictions are needed as with other MAOI drugs. The drug was researched by Joseph Knoll.
 |
|
 |
 |
 |
 |
 |
 |
|
| Sponsored Links: San Diego Real Estate Attorneys | Legal Source Diretory |
Comments on Selegiline (Deprenyl)